Guardant Health
GH
#1042
Rank
โ‚น2.212 T
Marketcap
โ‚น16,484
Share price
-8.83%
Change (1 day)
193.07%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น320.40

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น337.04. In 2025 the company made an earnings per share (EPS) of -โ‚น319.65 an increase over its 2024 EPS that were of -โ‚น343.80.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น320.400.23%
2025-โ‚น319.65-7.02%
2024-โ‚น343.80-16.82%
2023-โ‚น413.33-33.13%
2022-โ‚น618.0660%
2021-โ‚น386.2955.04%
2020-โ‚น249.16207.14%
2019-โ‚น81.12-19.81%
2018-โ‚น101.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น3.47-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น236.60-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA